239 related articles for article (PubMed ID: 22095285)
1. Mutation of ATF4 mediates resistance of neuronal cell lines against oxidative stress by inducing xCT expression.
Lewerenz J; Sato H; Albrecht P; Henke N; Noack R; Methner A; Maher P
Cell Death Differ; 2012 May; 19(5):847-58. PubMed ID: 22095285
[TBL] [Abstract][Full Text] [Related]
2. Basal levels of eIF2alpha phosphorylation determine cellular antioxidant status by regulating ATF4 and xCT expression.
Lewerenz J; Maher P
J Biol Chem; 2009 Jan; 284(2):1106-15. PubMed ID: 19017641
[TBL] [Abstract][Full Text] [Related]
3. ATF4 promotes angiogenesis and neuronal cell death and confers ferroptosis in a xCT-dependent manner.
Chen D; Fan Z; Rauh M; Buchfelder M; Eyupoglu IY; Savaskan N
Oncogene; 2017 Oct; 36(40):5593-5608. PubMed ID: 28553953
[TBL] [Abstract][Full Text] [Related]
4. Gamma-tocopheryl quinone, not alpha-tocopheryl quinone, induces adaptive response through up-regulation of cellular glutathione and cysteine availability via activation of ATF4.
Ogawa Y; Saito Y; Nishio K; Yoshida Y; Ashida H; Niki E
Free Radic Res; 2008 Jul; 42(7):674-87. PubMed ID: 18654882
[TBL] [Abstract][Full Text] [Related]
5. Activated Integrated Stress Response Induced by Salubrinal Promotes Cisplatin Resistance in Human Gastric Cancer Cells via Enhanced xCT Expression and Glutathione Biosynthesis.
Wang SF; Wung CH; Chen MS; Chen CF; Yin PH; Yeh TS; Chang YL; Chou YC; Hung HH; Lee HC
Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30380689
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial dysfunction enhances cisplatin resistance in human gastric cancer cells via the ROS-activated GCN2-eIF2α-ATF4-xCT pathway.
Wang SF; Chen MS; Chou YC; Ueng YF; Yin PH; Yeh TS; Lee HC
Oncotarget; 2016 Nov; 7(45):74132-74151. PubMed ID: 27708226
[TBL] [Abstract][Full Text] [Related]
7. ATF4 suppresses hepatocarcinogenesis by inducing SLC7A11 (xCT) to block stress-related ferroptosis.
He F; Zhang P; Liu J; Wang R; Kaufman RJ; Yaden BC; Karin M
J Hepatol; 2023 Aug; 79(2):362-377. PubMed ID: 36996941
[TBL] [Abstract][Full Text] [Related]
8. Induction of Nrf2 and xCT are involved in the action of the neuroprotective antibiotic ceftriaxone in vitro.
Lewerenz J; Albrecht P; Tien ML; Henke N; Karumbayaram S; Kornblum HI; Wiedau-Pazos M; Schubert D; Maher P; Methner A
J Neurochem; 2009 Oct; 111(2):332-43. PubMed ID: 19694903
[TBL] [Abstract][Full Text] [Related]
9. Regulation of xCT expression and system x (c) (-) function in neuronal cells.
Lewerenz J; Maher P; Methner A
Amino Acids; 2012 Jan; 42(1):171-9. PubMed ID: 21369940
[TBL] [Abstract][Full Text] [Related]
10. Nrf2- and ATF4-dependent upregulation of xCT modulates the sensitivity of T24 bladder carcinoma cells to proteasome inhibition.
Ye P; Mimura J; Okada T; Sato H; Liu T; Maruyama A; Ohyama C; Itoh K
Mol Cell Biol; 2014 Sep; 34(18):3421-34. PubMed ID: 25002527
[TBL] [Abstract][Full Text] [Related]
11. Enhanced expression of cystine/glutamate transporter in the lung caused by the oxidative-stress-inducing agent paraquat.
Kobayashi S; Kuwata K; Sugimoto T; Igarashi K; Osaki M; Okada F; Fujii J; Bannai S; Sato H
Free Radic Biol Med; 2012 Dec; 53(12):2197-203. PubMed ID: 23085521
[TBL] [Abstract][Full Text] [Related]
12. Expression of xCT and activity of system xc(-) are regulated by NRF2 in human breast cancer cells in response to oxidative stress.
Habib E; Linher-Melville K; Lin HX; Singh G
Redox Biol; 2015 Aug; 5():33-42. PubMed ID: 25827424
[TBL] [Abstract][Full Text] [Related]
13. Increased expression of cystine/glutamate antiporter in multiple sclerosis.
Pampliega O; Domercq M; Soria FN; Villoslada P; Rodríguez-Antigüedad A; Matute C
J Neuroinflammation; 2011 Jun; 8():63. PubMed ID: 21639880
[TBL] [Abstract][Full Text] [Related]
14. Thiol starvation triggers melanoma state switching in an ATF4 and NRF2-dependent manner.
Meinert M; Jessen C; Hufnagel A; Kreß JKC; Burnworth M; Däubler T; Gallasch T; Xavier da Silva TN; Dos Santos AF; Ade CP; Schmitz W; Kneitz S; Friedmann Angeli JP; Meierjohann S
Redox Biol; 2024 Apr; 70():103011. PubMed ID: 38219574
[TBL] [Abstract][Full Text] [Related]
15. Cooperative action of glutamate transporters and cystine/glutamate antiporter system Xc- protects from oxidative glutamate toxicity.
Lewerenz J; Klein M; Methner A
J Neurochem; 2006 Aug; 98(3):916-25. PubMed ID: 16771835
[TBL] [Abstract][Full Text] [Related]
16. Cystine-glutamate antiporter xCT as a therapeutic target for cancer.
Liu L; Liu R; Liu Y; Li G; Chen Q; Liu X; Ma S
Cell Biochem Funct; 2021 Mar; 39(2):174-179. PubMed ID: 32749001
[TBL] [Abstract][Full Text] [Related]
17. The mTORC1-mediated activation of ATF4 promotes protein and glutathione synthesis downstream of growth signals.
Torrence ME; MacArthur MR; Hosios AM; Valvezan AJ; Asara JM; Mitchell JR; Manning BD
Elife; 2021 Mar; 10():. PubMed ID: 33646118
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional control of cystine/glutamate transporter gene by amino acid deprivation.
Sato H; Nomura S; Maebara K; Sato K; Tamba M; Bannai S
Biochem Biophys Res Commun; 2004 Dec; 325(1):109-16. PubMed ID: 15522208
[TBL] [Abstract][Full Text] [Related]
19. 4-Hydroperoxy-2-decenoic acid ethyl ester protects against 6-hydroxydopamine-induced cell death via activation of Nrf2-ARE and eIF2α-ATF4 pathways.
Inoue Y; Hara H; Mitsugi Y; Yamaguchi E; Kamiya T; Itoh A; Adachi T
Neurochem Int; 2018 Jan; 112():288-296. PubMed ID: 28823537
[TBL] [Abstract][Full Text] [Related]
20. Astrocytes release glutamate via cystine/glutamate antiporter upregulated in response to increased oxidative stress related to sporadic amyotrophic lateral sclerosis.
Kazama M; Kato Y; Kakita A; Noguchi N; Urano Y; Masui K; Niida-Kawaguchi M; Yamamoto T; Watabe K; Kitagawa K; Shibata N
Neuropathology; 2020 Dec; 40(6):587-598. PubMed ID: 33305472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
